An overview of proteomic and metabolomic technologies and their application to pregnancy research

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 116, Issue 2, 2009, Pages 173-181

  Horgan, R P ^a,b   Clancy, O H ^a   Myers, J E ^a   Baker, P N ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

Metabolomics; Pregnancy; Proteomics; Research; Technology

Indexed keywords

DISEASE MARKER; ELECTROSPRAY MASS SPECTROMETRY; EXPERIMENTAL DESIGN; GENE INTERACTION; GYNECOLOGY; HIGH RISK PATIENT; HUMAN; INTRAUTERINE GROWTH RETARDATION; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; METABOLOMICS; MOLECULAR THERAPY; OBSTETRICS; PATHOPHYSIOLOGY; PREECLAMPSIA; PREGNANCY; PREMATURE LABOR; PRIORITY JOURNAL; PROTEOMICS; REVIEW; STILLBIRTH;

COMPUTATIONAL BIOLOGY; FEMALE; FORECASTING; HUMANS; METABOLOMICS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY, HIGH-RISK; PROTEOMICS;

EID: 57449096548     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2008.01997.x     Document Type: Review

References (70)

1. Peng J, Gygi S. Proteomics: the move to mixtures. J Mass Spectrom 2001 36 : 1083 91.
2. Theodorescu D, Mischak H. Mass spectrometry based proteomics in urine biomarker discovery. World J Urol 2007 25 : 435 43.
3. Petricoin EF, Zoon KC, Kohn EC, Barrett JC, Liotta LA. Clinical proteomics: translating benchside promise into bedside reality Nat Rev Drug Discov 2002 1 : 683 95.
4. Vlahou A, Fountoulakis M. Proteomic approaches in the search for disease biomarkers. J Chromatogr B Analyt Technol Biomed Life Sci 2005 814 : 11 19.
5. Goodacre R, Vaidyanathan S, Dunn WB, Harrigan GG, Kell DB. Metabolomics by numbers: acquiring and understanding global metabolite data. Trends Biotechnol 2004 22 : 245 52.
6. Horning EC. Use of combined gas-liquid chromatography and mass spectrometry for clinical problems. Clin Chem 1968 14 : 777.
7. Pauling L, Robinson AB, Teranish R, Cary P. Quantitative analysis of urine vapor and breath by gas-liquid partition chromatography. Proc Natl Acad Sci U S A 1971 68 : 2374 76.
8. Oliver SG, Winson MK, Kell DB, Baganz F. Systematic functional analysis of the yeast genome. Trends Biotechnol 1998 16 : 373 8.
9. Thongboonkerd V. Practical points in urinary proteomics. J Proteome Res 2007 6 : 3881 90.
10. Rifai N, Gillette M, Carr S. Protein biomarker discovery and validation: the long and uncertain path to clinical utility. Nat Biotechnol 2006 24 : 971 83.
11. Etzioni R, Urban N, Ramsey S, McIntosh M, Schwartz S, Reid B, et al. The case for early detection. Nat Rev Cancer 2003 3 : 243 52.
12. Anderson NL, Anderson NG. The human plasma proteome: history, character and diagnostic prospects. Mol Cell Proteomics 2002 1 : 845 67.
13. Barratt J, Topham P. Urine proteomics: the present and future of measuring urinary protein components in disease. CMAJ 2007 177 : 361 8.
14. Crameri R. The potential of proteomics and peptidomics for allergy and asthma research. Allergy 2005 60 : 1227 37.
15. Zimmerli L, Schiffer E, Zuberg P, Good D, Kellmann M, Mouls L, et al. Urinary proteomic biomarkers in coronary artery disease. Mol Cell Proteomics 2008 7 : 290 8.
16. Zhang J, Sokal I, Peskind ER, Quinn JF, Jankovic J, Kenney C, et al. CSF multianalyte profile distinguishes Alzheimer and Parkinson diseases. Am J Clin Pathol 2008 129 : 526 9.
17. Bertucci F, Goncalves A. Clinical proteomics and breast cancer: strategies for diagnostic and therapeutic biomarker discovery. Future Oncol 2008 4 : 271 87.
18. Thongboonkerd V, Malasit P. Renal and urinary proteomics: current applications and challenges. Proteomics 2005 5 : 10233 42.
19. Kell DB. Systems biology, metabolic modelling and metabolomics in drug discovery and development. Drug Discov Today 2006 11 : 1085 92.
20. Brindle JT, Antti H, Holmes E, Tranter G, Nicholson JK, Bethell HWL, et al. Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using H-1-NMR-based metabonomics. Nat Med 2002 8 : 1439 44.
21. Pisikun T, Johnstone R, Knepper M. Discovery of urinary biomarkers. Mol Cell Proteomics 2006 5 : 1760 71.
22. Annual report. Dublin : N.M. Hospital, 1991.
23. Sim D, Beattie RB, Dornan JC. Evaluation of biophysical fetal assessment in high-risk pregnancy to assess ultrasound parameters suitable for screening in the low-risk population. Ultrasound Obstet Gynecol 1993 3 : 11 17.
24. Kenny LC, Dunn WB, Ellis DI, Myers JE, Robinson AE, Kell DB, et al. Novel biomarkers for preeclampsia detected using metabolomics and machine learning. J Soc Gynecol Investig 2005 12 : 199A.
25. Goodacre R. Metabolomics of a superorganism. J Nutr 2007 137 : 259S 66S.
26. Oh JE, Krapfenbauer K, Fountoulakis M, Frischer T, Lubec G. Evidence for the existence of hypothetical proteins in human bronchial epithelial, fibroblast, amnion, lymphocyte, mesothelial and kidney cell lines. Amino Acids 2004 26 : 9 18.
27. Duarte NC, Becker SA, Jamshidi N, Thiele I, Mo ML, Vo TD, et al. Global reconstruction of the human metabolic network based on genomic and bibliomic data. Proc Natl Acad Sci U S A 2007 104 : 1777 82.
28. Kussmann M, Raymond F, Affolter M. OMICS-driven biomarker discovery in nutrition and health. J Biotechnol 2006 124 : 758 87.
29. Lindsey M. Target discovery. Nat Rev Drug Discov 2003 2 : 831 8.
30. Urbanczyk-Wochniak E, Luedemann A, Kopka J, Selbig J, Roessner-Tunali U, Willmitzer L, et al. Parallel analysis of transcript and metabolic profiles: a new approach in systems biology. EMBO Rep 2003 4 : 989 93.
31. Kell DB, Oliver SG. Here is the evidence, now what is the hypothesis? The complementary roles of inductive and hypothesis-driven science in the post-genomic era. Bioessays 2004 26 : 99 105.
32. Dunn WB, Broadhurst D, Ellis DI, Brown M, Halsall A, O'Hagan S, et al. A GC-TOF-MS study of the stability of serum and urine metabolomes during the UK Biobank sample collection and preparation protocols. Int J Epidemiol 2008 37 (Suppl 1 i23 30.
33. Fenn J, Mann M, Meng C, Wong S, Whitehouse C. Electrospray ionisation for mass spectrometry of large biomolecules. Science 1988 246 : 64 71.
34. Karas M, Hillenkamp F. Laser desorption ionization of proteins with molecular masses exceeding 10,000 daltons. Anal Chem 1988 60 : 2299 301.
35. O'Riordan E, Gross SS, Goligorsky MS. Technology insight: renal proteomics - at the crossroads between promise and problems. Nat Clin Pract Nephrol 2006 2 : 445 58.
36. Mann M, Hendrickson RC, Pandey A. Analysis of protiens and proteomics by mass spectrometry. Annu Rev Biochem 2001 70 : 437 73.
37. Gonzalez-Buitrago JM, Ferreira L, Lorenzo I. Urinary proteomics. Clin Chim Acta 2007 375 : 49 56.
38. Domon B, Aebersold R. Mass spectrometry and protein analysis. Science 2006 312 : 212 17.
39. Hu Q, Noll RJ, Makarov A, Hardman M, Cooks R. The orbitrap: a new mass spectrometer. J Mass Spectrom 2005 40 : 430 43.
40. MacBeath G, Schreiber SL. Printing proteins as microarrays for high-throughput function determination. Science 2000 289 : 1760 3.
41. Tang N, Tornature P, Weinberger SR. Current developments in SELDI affinity technology. Mass Spectrom Rev 2004 23 : 34 44.
42. Van den Berg G, Arckens L. Fluorescent two-dimensional difference gel electrophoresis unveils the potential of gel-based proteomics. Curr Opin Biotechnol 2004 15 : 38 43.
43. Unwin R, Whetton A. How will haematologists use proteomics? Blood Rev 2007 21 : 315 26.
44. Pierce A, Unwin RD, Evans CA, Griffiths S, Carney L, Zhang L, et al. Eight-channel iTRAQ enables comparison of the activity of 6 leukaemogenic tyrosine kinases. Mol Cell Proteomics 2008 7 : 853 63.
45. Bergeron JJ, Hallett M. Peptides you can count on. Nat Biotechnol 2007 25 : 61 2.
46. Aggarwal K, Choe L, Lee K. Shotgun proteomics using the iTRAQ isobaric tags. Brief Funct Genomic Proteomics 2006 5 : 112 20.
47. Dunn WB. Current trends and future requirements for the mass spectrometric investigation of microbial, mammalian and plant metabolomes. Phys Biol 2008 5 : 11001.
48. Broadhurst DI, Kell DB. Statistical strategies for avoiding false discoveries in metabolomics and related experiments. Metabolomics 2006 2 : 171 96.
49. Fiehn O, Robertson D, Griffin J, van der Werf M, Nikolau B, Morrison N, et al. The metabolomics standards initiative (MSI). Metabolomics 2007 3 : 175 8.
50. Hoang V, Foulk R, Clauser K, Burlingame A, Gibson B, Fisher S. Functional proteomics: examining the effects of hypoxia on the cytotrophoblast protein repertoire. Biochemistry 2001 40 : 4077 86.
51. Sawicki G, Dakour J, Morrish DW. Functional proteomics of neurokinin B in the placenta indicates a novel role in regulating cytotrophoblast antioxidant defences. Proteomics 2003 3 : 2044 51.
52. Heazell AE, Lacey HA, Jones CJ, Huppertz B, Baker PN, Crocker IP. Effects of oxygen on cell turnover and expression of regulators of apoptosis in human placental trophoblast. Placenta 2008 29 : 175 86.
53. Heazell A, Brown M, Dunn W, Worton S, Crocker I, Baker P, et al. Analysis of the metabolic footprint and tissue metabolome of placental villous explants cultured at different oxygen tensions reveals novel redox biomarkers. Placenta 2008 15 : 318A.
54. Wang C, Wing Yim C, Poon T, Choy K, Chu C, Lui W, et al. Innate immune response by ficolin binding in apoptotic placenta is associated with the clinical syndrome of preeclampsia. Clin Chem 2007 53 : 42 52.
55. Sun LZ, Yang NN, De W, Xiao YS. Proteomic analysis of proteins differentially expressed in preeclamptic trophoblasts. Gynecol Obstet Invest 2007 64 : 17 23.
56. Vascotto C, Salzano AM, D'Ambrosio C, Fruscalzo A, Marchesoni D, di Loreto C, et al. Oxidized transthyretin in amniotic fluid as an early marker of preeclampsia. J Proteome Res 2007 6 : 160 70.
57. Butt RH, Lee MW, Pirshahid SA, Backlund PS, Wood S, Coorssen JR. An initial proteomic analysis of human preterm labor: placental membranes. J Proteome Res 2006 5 : 3161 72.
58. Perieira L, Reddy AP, Jacob T, Thomas A, Schneider KA, Dasari S, et al. Identification of novel protein biomarkers of preterm birth in human cervical-vaginal fluid. J Proteome Res 2007 6 : 1269 76.
59. Cho CK, Sahn SJ, Winsor EJ, Diamandis EP. Proteomics analysis of human amniotic fluid. Mol Cell Proteomics 2007 9 : 1406 15.
60. Gagnon A, Kim JH, Schorge JO, Ye B, Liu B, Hasselblatt K, et al. Use of a combination of approaches to identify and validate relevant tumor-associated antigens and their corresponding autoantibodies in ovarian cancer patients. Clin Cancer Res 2008 14 : 764 71.
61. Petricoin EF, Ardekani AM, Hitt BA, Levine PJ, Fusaro VA, Steinberg SM, et al. Use of proteomic patterns in serum to identify ovarian cancer. Lancet 2002 359 : 572 7.
62. Romero R, Gomez R, Nien JK, Yoon BH, Luo R, Beecher C, et al. Metabolomics in premature labor: a novel approach to identify patients at risk for preterm delivery. Am J Obstet Gynecol 2004 191 : S2.
63. Morgan L. Disentangling fetal and maternal susceptibility for pre-eclampsia: a British multicenter candidate-gene study. Am J Hum Genet 2005 77 : 127 31.
64. Kenny LC, Broadhurst D, Brown M, Dunn WB, Redman CW, Kell DB, et al. Detection and identification of novel metabolomic biomarkers in preeclampsia. Reprod Sci 2008 15 : 591 7.
65. Turner E, Brewster JA, Simpson NAB, Walker JJ, Fisher J. Plasma from women with Preeclampsia has a low lipid and ketone body content - a nuclear magnetic resonance study. Hypertens Pregnancy 2007 26 : 329 42.
66. Seli E, Sakkas D, Scott R, Kwok SC, Rosendahl SM, Burns DH. Noninvasive metabolomic profiling of embryo culture media using Raman and near-infrared spectroscopy correlates with reproductive potential of embryos in women undergoing in vitro fertilization. Fertil Steril 2007 88 : 1350 7.
67. Singh R, Sinclair KD. Metabolomics: approaches to assessing oocyte and embryo quality. Theriogenology 2007 68 (Suppl 1 S56 62.
68. Shankar R, Cullinane F, Brennecke SP, Moses EK. Applications of proteomic methodologies to human pregnancy research: a growing gestation approaching delivery? Proteomics 2004 4 : 1909 17.
69. Hanash S. HUPO initiatives relevant to clinical proteomics. Mol Cell Proteomics 2004 3 : 298 301.
70. Dunn WB, Bailey NJC, Johnson HE. Measuring the metabolome: current analytical technologies. Analyst 2005 130 : 606 25.